Gabelli Healthcare&wellness (GRX) Technical Analysis
$9.20▲0.55%
Market is closed - opens 7 PM, 20 Oct 2025
Insights
- Gabelli Healthcare&wellness is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Gabelli Healthcare&wellness stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Gabelli Healthcare&wellness stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Gabelli Healthcare&wellness stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 48.08 | Neutral |
Stochastic | 56.82, 51.52 | Neutral |
Ultimate Oscillator | 37.06 | Neutral |
Stochastic Relative Strength Index | 56.78, 60.4 | Neutral |
Moving Average Convergence Divergence | -0.02, -0.03 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.21 | Buy |
20 | 9.17 | Sell |
50 | 9.27 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.19 | Sell |
20 | 9.2 | Sell |
50 | 9.26 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.23 | Neutral |
20 | 9.17 | Neutral |
50 | 9.28 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.18 | Buy |
20 | 9.17 | Sell |
50 | 9.17 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.18 | Buy |
20 | 9.18 | Buy |
50 | 9.16 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 9.4 |
Resistance L2 | 9.34 |
Resistance L1 | 9.24 |
Pivot Point | 9.18 |
Support L1 | 9.08 |
Support L2 | 9.02 |
Support L3 | 8.92 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.